2015-07-23T10:27:56-05:00 2014-09-30 ERNST & YOUNG US LLP 200 CLARENDON STREET BOSTON MA 021165072 990 2013-10-01 042263040 Dana-Farber Cancer Institute Inc % STEVEN CONNOLLY DANA 6176323000 450 Brookline Avenue BP418 Suite Boston MA 02215 DOROTHY PUHY COO 2015-07-22 2013 2016-02-25 16:41:14Z Edward J Benz Jr MD 450 BROOKLINE AVE Boston MA 02215 1121897595 false X www.dana-farber.org X 1951 MA The mission of DFCI is to provide expert, compassionate care to COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER & ADVANCE THE TREATMENT, CURE, AND PREVENTION OF CANCER & RELATED DISEASES. 58 48 4875 5000 0 0 393393949 403408212 639632558 672381913 224324 206121 23590819 43146433 1056841650 1119142679 26833850 501770 0 0 369880843 383724145 3391495 3291750 23774916 623617670 675695790 1023723858 1063213455 33117792 55929224 1790428005 1950186370 608044913 637235449 1182383092 1312950921 THE MISSION OF DANA-FARBER CANCER INSTITUTE IS TO PROVIDE EXPERT, COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. AS AN AFFILIATE OF HARVARD MEDICAL SCHOOL AND A COMPREHENSIVE CANCER CENTER DESIGNATED BY THE NATIONAL CANCER INSTITUTE, THE INSTITUTE ALSO PROVIDES TRAINING FOR NEW GENERATIONS OF PHYSICIANS AND SCIENTISTS, DESIGNS PROGRAMS THAT PROMOTE PUBLIC HEALTH PARTICULARLY AMONG HIGH-RISK AND UNDERSERVED POPULATIONS, AND DISSEMINATES INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES TO OUR TARGET COMMUNITY ACROSS THE UNITED STATES AND THROUGHOUT THE WORLD. false false 561573102 672381913 Provided specialized, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. 271728921 Research at DFCI is staking out new territory in the fight against cancer, from advancing the understanding of the genetic makeup of cancer cells to developing novel therapies to diagnose, treat, and prevent the disease. 23728941 501770 Through DFCI's community benefits programs, DFCI works in collaboration with community organizations to promote greater public health. See the community benefits report general explanation included in Schedule H. 857030964 true true false true false false false true false true true false false true true false false true false false true true false true true false true true true false true true false false false false false true false true false true true true false false false true true true true false true 473 0 true 4875 true false true CJ false false false true true false false false false X 58 48 true false true false false false false true true false false true true true true true true true true false AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X STEVEN CONNOLLY 6176323000 C/O DFCI 450 BROOKLINE AVE BP418 Boston MA 02215 X Bekenstein Joshua Trustee & Chairman 2.0 0.0 X X 0 0 0 Benz Edward J JR MD Trustee, President and CEO 42.0 8.0 X X 1125110 133550 236817 Berkowitz Roger Trustee 1.0 0.0 X 0 0 0 Berylson Amy S Trustee 1.0 0.0 X 0 0 0 Brown HON Frederick Trustee 1.0 0.0 X 0 0 0 Champa Michael A Trustee 1.0 0.0 X 0 0 0 Countryman Gary L Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Cox Howard Trustee 1.0 0.0 X 0 0 0 Curtin Neal J ESQ Trustee & Secretary 2.0 0.0 X X 0 0 0 Dana Charles A III Trustee 1.0 0.0 X 0 0 0 Darehshori Nader F Trustee 1.0 0.0 X 0 0 0 DaSilva Kevin G Trustee 1.0 0.0 X 0 0 0 Dobson Sean Trustee 1.0 0.0 X 0 0 0 Farrington Thomas A Trustee 1.0 0.0 X 0 0 0 Fine James L Trustee 1.0 0.0 X 0 0 0 Fine Stephen A Trustee 1.0 0.0 X 0 0 0 First Deborah S Trustee 1.0 0.0 X 0 0 0 First Robert C Trustee 1.0 0.0 X 0 0 0 Foulkes Helena B Trustee 1.0 0.0 X 0 0 0 Gelb Arthur Sc D Trustee 1.0 0.0 X 0 0 0 Gibson Nancy Q Trustee 1.0 0.0 X 0 0 0 Grubman Richard Trustee 1.0 0.0 X 0 0 0 Hadley Christopher Trustee 1.0 0.0 X 0 0 0 Harkins David V Trustee 1.0 0.0 X 0 0 0 Heller Frances Trustee 1.0 0.0 X 0 0 0 Jamieson Jane P Trustee 1.0 0.0 X 0 0 0 Kafker Hon Scott Trustee 1.0 0.0 X 0 0 0 Kelley Joseph Trustee 1.0 0.0 X 0 0 0 Knez Brian J Trustee & Treasurer 2.0 0.0 X X 0 0 0 Koppel Steven P Trustee 1.0 0.0 X 0 0 0 Kopperl Paul B Trustee 1.0 0.0 X 0 0 0 Koster Stephen P ESQ Trustee 1.0 0.0 X 0 0 0 Kraft Robert K Trustee 1.0 0.0 X 0 0 0 Krakoff Sandra G Trustee 1.0 0.0 X 0 0 0 Lockwood Roger A Trustee 1.0 0.0 X 0 0 0 Lubin Richard K Trustee 1.0 0.0 X 0 0 0 Lucas Bradley A Trustee 1.0 0.0 X 0 0 0 Lucchino Lawrence Trustee 1.0 0.0 X 0 0 0 Marshall John L III Trustee 1.0 0.0 X 0 0 0 McNay Joseph C Trustee 1.0 0.0 X 0 0 0 Meagher William F Trustee 1.0 0.0 X 0 0 0 Morse Richard P Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Nathan David G MD Trustee & Physician 1.0 0.0 X 223789 0 40229 Norberg Joseph E Trustee 1.0 0.0 X 0 0 0 O'Connor John J Trustee 1.0 0.0 X 0 0 0 O'Reilly Vincent M Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Owens Edward O Trustee 1.0 0.0 X 0 0 0 Packman Karen Linde Trustee 1.0 0.0 X 0 0 0 Palandjian Peter Trustee 1.0 0.0 X 0 0 0 Pasquarello Theodore Trustee 1.0 0.0 X 0 0 0 Pearlstein Jean F Trustee 1.0 0.0 X 0 0 0 Perini David B Trustee 1.0 0.0 X 0 0 0 Perini Eileen Trustee 1.0 0.0 X 0 0 0 Perini Jennifer Trustee 1.0 0.0 X 0 0 0 Perlmutter Steven P ESQ Trustee 1.0 0.0 X 0 0 0 Poduska Susan M Trustee 1.0 0.0 X 0 0 0 Pohl Elizabeth Trustee 1.0 0.0 X 0 0 0 Reynolds Robert Trustee 1.0 0.0 X 0 0 0 Rosenberg Ann M Trustee 1.0 0.0 X 0 0 0 Rosenthal Harvey Trustee 1.0 0.0 X 0 0 0 Rover Edward F Trustee 1.0 0.0 X 0 0 0 Sachs Robert J ESQ Trustee 1.0 0.0 X 0 0 0 Salter Malcolm S Trustee 1.0 0.0 X 0 0 0 Sanders Rebecca Trustee 1.0 0.0 X 0 0 0 Sen Laura Trustee 1.0 0.0 X 0 0 0 Smith Richard A Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Smith Susan F Trustee 1.0 0.0 X 0 0 0 Socol Jerry M Trustee 1.0 0.0 X 0 0 0 Spivak Gloria H Trustee 1.0 0.0 X 0 0 0 Stansky Robert Trustee 1.0 0.0 X 0 0 0 Sullivan Ronald S Jr Trustee 1.0 0.0 X 0 0 0 Tempel Jean C Trustee 1.0 0.0 X 0 0 0 Terrana Beth F Trustee 1.0 0.0 X 0 0 0 Ting David T Trustee 1.0 0.0 X 0 0 0 Williams Frederica M Trustee 1.0 0.0 X 0 0 0 Yost George J III Trustee 1.0 0.0 X 0 0 0 Alexander Susan Trusteee 1.0 0.0 X Cohen Mark A Trustee 1.0 0.0 X Gosman Abraham D Trustee 1.0 0.0 X Gross Phillip Trustee 1.0 0.0 X Kyle Amy Trustee 1.0 0.0 X Marcus Paul Trustee 1.0 0.0 X Salmon Marjorie B Trustee 1.0 0.0 X Schlager Eric Trustee 1.0 0.0 X Boskey Richard S ESQ Asst Sec & General Counsel 50.0 0.0 X 536581 0 64665 Puhy Dorothy COO & EVP 50.0 0.0 X 744782 0 45728 Bird Karen CFO & Asst. Treasurer 50.0 0.0 X 452742 0 64945 Bartel Sylvia VP of Pharmacy Services 50.0 0.0 X 228826 0 55304 Bunnell Craig A MD Chief Medical Officer 50.0 0.0 X 467420 0 44981 Gettleman Wendy VP of Facilities Management 50.0 0.0 X 209423 0 57977 Griffin James D MD Chair of Medical Oncology 50.0 0.0 X 658460 0 58949 Johnson Bruce Chief Clinical Research Office 50.0 0.0 X 498064 0 71974 Megdal Maria SVP of Institute Operations 50.0 0.0 X 342592 0 48636 Paresky Susan SVP of Development 50.0 0.0 X 603703 0 60847 Rollins Barrett J MD PHD Chief Scientific Officer 50.0 0.0 X 620128 0 50281 Shulman Lawrence N MD Chief of Staff 50.0 0.0 X 690523 0 55604 Constantine Michael MD Milford Med Dir-Hematol Onc 50.0 0.0 X 766994 0 47267 Kaddis Mona MD Medical Oncologist Milford 50.0 0.0 X 663013 0 33746 Kantoff Phillip MD Chief Clinical Research Office 50.0 0.0 X 602484 0 63622 Nadler Lee MD SVP for Experimental Med 50.0 0.0 X 651092 0 59855 Winer Eric MD Chief of Div of Women's Cancer 50.0 0.0 X 584911 0 73453 Herring Thomas Former Key Employee 24.0 0.0 X 138271 0 31844 Reid Ponte Patricia Former Key Employee 50.0 0.0 X 419666 0 51324 Sallan Stephen E MD Former Key Employee 50.0 0.0 X 503827 0 58232 11732401 133550 1376280 816 true true false Walsh Brothers Inc 210 Commercial Street BOSTON MA 02109 Construction Service 20428927 Partners Healthcare System Inc PO Box 3715 BOSTON MA 02241 Information Systems 56430827 Brigham and Women's Physicians Org 111 Cypress Street BROOKLINE MA 02445 Medical Services 12389233 Harvard University 1350 Massachusetts Ave CAMBRIDGE MA 02138 Research Services 14105824 The Brigham and Women's Hospital 75 Francis Street BOSTON MA 02115 Medical Services 48719894 421 345683 24213096 121836306 257013127 5655011 403408212 NET PATIENT SERVICE REVENUE 621110 672381913 672381913 672381913 206121 206121 0 25378060 25378060 5359805 5359805 0 5359805 5359805 0 739337 24213096 2754916 -2015579 -2015579 0 0 PARKING LOT REVENUE 812930 5334409 5334409 FOOD SERVICE REVENUE 722210 3655355 3655355 WCP BOUTIQUE INCOME 446199 1171594 1171594 4262789 4262789 14424147 1119142679 672381913 43352554 501770 501770 0 0 0 8214197 3800043 3733905 680249 0 305589171 235420021 56907734 13261416 19334042 14762309 3719596 852137 28299776 21608004 5444476 1247296 22286959 17016979 4287695 982285 6699571 1865260 4834311 4587130 3750199 827662 9269 444599 444599 265858 265858 3291750 3291750 0 128259505 109654675 18249039 355791 8294205 2160077 5137923 996205 30370308 21052279 8543690 774339 48155595 16729389 31406956 19250 0 66825049 52075212 14749837 9003732 3516735 5407837 79160 0 3444334 1240762 1098160 1105412 12490103 12490103 0 61113251 49845590 11267661 4248968 2897671 1351297 OTHER PATIENT CARE EXPENSES 19800486 19800486 MISCELLANEOUS 28836615 23721061 4995197 120357 MEDICAL SUPPLIES EXPENSE 242856481 242856481 1063213455 857030964 182407575 23774916 0 0 61796976 298937 72699473 60980093 99585081 102232434 1136762 1047696 0 0 0 0 13218325 15517529 17195831 20217077 1282734123 590144649 646076688 692589474 0 0 0 0 0 0 7894580 7894580 870824289 1049408550 1790428005 1950186370 87118430 101527511 0 0 0 0 279981307 276408738 0 0 0 0 84516167 82808737 0 0 156429009 176490463 608044913 637235449 X 556219441 607664709 467303055 538069716 158860596 167216496 1182383092 1312950921 1790428005 1950186370 X 55929224 74638605 X false true X true true true X 308112408 440670897 398632881 393393949 403408212 1944218347 0 0 308112408 440670897 398632881 393393949 403408212 1944218347 0 1944218347 12834800 12603828 10185220 12285983 30943986 78853817 1147 1147 7853536 10965879 11866982 14090598 15163484 59940479 2083013790 2274683403 0.93337 0.94580 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true false true false true 265858 true 13437 false false 279295 false Supplemental Lobbying Information O'NEILL, ATHY & CASEY, P.C. - provided federal legislative and government relations consulting services to the Conference of Boston Teaching Hospitals, of which we are a member. VAN SCOYOC - provided federal legislative consulting to DFCI. MCDERMOTT, QUILTY & MILLER, LLP - provided state legislative and government relations consulting on health interests to DFCI. CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. On occasion, DFCI executive leadership meet with state and federal elected officials to advocate for the passage of legislation and funding to advance cancer research and treatment, and legislation to support services for cancer patients and cancer survivors. 1640257 X false 231119000 11556000 22937000 14962000 250650000 207975000 9214000 27582000 13652000 231119000 187242000 9879000 22169000 11315000 207975000 179577000 9098000 8614000 10047000 187242000 158022000 7951000 18605000 5001000 179577000 0.69000 0.31000 false true true 7640445 7640445 742025187 303337741 438687446 135078856 73131829 61947027 283401263 213675079 69726184 114588372 114588372 692589474 INTEREST IN DANA-FARBER, INC. 976053795 MISCELLANEOUS ASSETS 65156755 INTEREST IN DFCCN 8198000 1049408550 0 AMOUNTS DUE TO 3RD PARTY PAYOR 72867109 RESEARCH ADVANCES 41880000 PROV FOR MED MALPRACTICE CLAIM 1277000 SWAP VALUATION LIABILITY 37178000 MISCELLANEOUS LIABILITIES 23288354 176490463 SCHEDULE D PART III, QUESTION 4 DFCI's collection of art is an array of art primarily received through donations and occasionally purchased. The collection can be found throughout the organization in patient and business areas. Patients and staff confirm the Institute's belief that artwork which is pleasing and appropriate for a health care setting greatly enhances the healing environment and makes a significant difference in the patient care experience. Schedule D, Part V, Question 4 Dana-Farber, Inc. (DFI) a related organization of Dana-Farber Cancer Institute, Inc. (DFCI) holds the endowments for DFCI and therefore reports the endowment funds on DFI's 990 accordingly. As described in detail in the Consolidated Audited Financial Statements, the Institute's endowments consist of numerous individual funds established for a variety of purposes. These endowments consist solely of donor-restricted endowment funds. As required by Generally Accepted Accounting Principles, net assets associated with endowment funds are classified and reported based on the existence or absence of donor-imposed restrictions. All uses of the organization's endowment funds are directly related to the Institute's exempt mission and purposes. South Asia Program Services Subcontracted Research 249510 North America Program Services Subcontracted Research 614302 Europe (Including Iceland and Greenland) Program Services Subcontracted Research 591362 East Asia and the Pacific Program Services Subcontracted Research 185778 South America Program Services Subcontractor Research 63013 Central America and the Caribbean Program Services Jointly owned for Ins 2841479 4545444 4545444 true false true false false false X X X X X X X true STRATEGIC FUNDRAISING telefundrai consulting false 257308 196010 61298 TRUESENSE MARKETING Direct Mail Consultant false 10541377 2990740 7550637 Dave Mcgillivray Sports Enterprise Event Logis false 105000 10798685 3291750 7611935 All States Marathon Chlng 8178693 7990243 188450 38091 7388 471550 BMJF Walk 8049000 7858538 190462 130635 5274 7400 823195 7 8724740 8364315 360425 36399 18833 1216151 24952433 24213096 739337 205125 31495 7400 2510896 2754916 -2015579 true true X true X 133. true X true true false true true 15460393 11417567 4042826 0.00380 30624247 31218892 -594646 7941542 7941542 0.00750 54026182 42636459 11389722 0.01130 2672461 2672461 0.00250 4794880 499473 4295407 0.00400 257266539 229997859 27268680 0.02570 315223 315223 0.00030 265049103 230497332 34551771 0.03250 319075285 273133791 45941493 0.04380 568607 568607 0.00050 391000 391000 0.00040 959607 959607 0.00090 true 4183567 41836 144135634 160028087 -15892453 true true 1 1 DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVE BOSTON MA 02215 www.dana-farber.org X X X D-F/BWH @ FAULKNER, MILFORD, SOUTH Shore D-F @ st elizabeth's DANA-FARBER CANCER INSTITUTE INC true X X X X X X X X X 12 true false true X X X X X X X X X X true false true true 133. true 300. true X X X X X X X true true X X X X X X true false X X X true X false false Part V, Section B Part V, Section B, Line 3 The DFCI's Community Benefits Office partnered with Health Resources in Action (HRiA), a non-profit public health consultancy organization in Boston, to undertake a two phase comprehensive community health assessment. In Phase I, social, economic, and epidemiological data at the community level were reviewed and analyzed to provide a health portrait of DFCI's priority communities (Roxbury, Mission Hill, Dorchester, Mattapan, and Jamaica Plain). Phase II involved a comprehensive qualitative study, where DFCI staff, community leaders, and residents provided feedback in focus groups and interviews to identify community needs and assets as well as areas for further community engagement and program expansion. Focus groups included staff members from the following community organizations: Roxbury Tenants, Boston Public Health Commission, Roxbury Comprehensive Health Center, Boston Asian: Yes, Tobin Community Center, Mission Hill Neighborhood Housing Services. In addition, community residents participated in focus groups hosted by Whittier Street Health Center and La Alianza Hispana. Additionally, the Community Benefits External Advisory Committee members and DFCI Trustees Community Programs Committee provided guidance, oversight and input. A total of 86 individuals participated in the Phase II qualitative research in order to gauge their perceptions of their neighborhood, their health concerns, what programming or services are most needed to address these concerns, and the role of DFCI in these efforts. Please see attached Community Health Needs Assessment Implementation Plan 2012-2015 Part V, Section B, Line 5a DFCI's implementation strategy is available on the DFCI website. http://www.dana-farber.org/About-Us/Community-Outreach/Community-Health-Ne eds-Assessment-Reporting.aspx http://www.dana-farber.org/uploadedFiles/Library/about-us/community-outrea ch/chna-implementation-plan.pdf Part V, Section B, Line 14 b Billing invoices include Free Care Guidelines and contact information for financial assistance. Part V, Section B, Line 14 g The Insurance and Financial Assistance section of the DFCI website directs patient to financial counselors for guidance. Part V, Section B, Line 19 Due to the fact DFCI is a Cancer Institute it rarely provides emergency services. However, DFCI will provide emergent and urgent care without regard to the patient's identification, insurance coverage or ability to pay for services in accordance with the requirements of DFCI policy. In all of its patient care activities, DFCI shall remain in compliance with federal regulations such as title 42 Chapter 7 USC 1395 (DD) and the balanced budget act of 1998 (Public Law No 105.33). Part V, Line 20d In no event is a patient who has been determined to be eligible for financial assistance from DFCI charged more than the maximum amounts billed to other insured patients for emergency or medically necessary care, as determined in accordance with the "look-back" method descried in "Internal Revenue Service, Proposed Treasury Regulation Section 1.501(r), Additional Requirements for Charitable Hospitals; Proposed Rule (June 26, 2012). 1 DANA-FARBERNHOH ELLIOTT MED CENTER 40 BUTTRICK RD LONDONDERRY NH 03053 MED ONCOLOGY & INFUSION UNIT Part I Part I, Line 3c Pursuant to its written policy Dana-Farber Cancer Institute (DFCI) provides financial assistance to patients based on their family income level and in certain cases based on the family's excessive medical expenses relative to family income. In addition, DFCI provides a forty-five (45%) discount to all uninsured patients. Part I, Line 6a The community benefit report was completed by DFCI and is annually provided to the Massachusetts Attorney General's office, where it is then made public on their website. Part I, Line 7 DFCI's internal cost accounting system, which accounts for all Institute activity, was used to create the cost to charge ratio that was applied to charity care charges to determine the financial assistance cost (Line 7a). Line 7c reflects the specific cost incurred for the Institute's required funding of the State's Health Safety Net fund. Line 7f reflects the costs of education, as calculated on the Medicare cost report, less any applicable reimbursement received for it. Part I Line 7h DFCI devoted $85,754,659 of funds from individual gifts and commercial agreements, which are not includable in line 7h, to further its research mission of staking out new territory in the fight against cancer, from advancing the understanding of the genetic makeup of cancer cells to developing novel therapies to diagnose, treat, and prevent the disease. Part I Line 7h Column d DFCI's 2014 Direct Offsetting Research Revenue includes $218,572,784 of restricted grants received by the Institute to further its research mission. Based on the prior instructions to this Form 990, this funding has historically been excluded from the calculation of the organization's Direct Offsetting Research Revenue, and therefore its community benefit expenses. The result of this reporting change is a reduction of the research portion of DFCI's community benefit expense total from 21.09% last year to 2.57% this year. This difference is not reflective of any material change in DFCI's sources of funding or the benefit provided to the community through its research activities. Part II Part II, Line 1 Physical Improvements and housing-DFCI provides a limited number of low cost rooms that serve as a home away from home for oncology patients and their families while they are receiving treatment. Part II, Line 8 Diversity and Workforce Development: In collaboration with nearby health care institutions, DFCI offers English as a Second Language (ESL) classes to staff. Business Writing for Professionals is an onsite 6-month college prep course designed to help front-line employees enhance reading and writing skills necessary for success in the workplace and in the classroom. DFCI also continued its collaboration with The Partnership to train and to increase the number of people of color in leadership roles in the Boston community. DFCI has continued its collaboration with the YMCA Achievers Program to recognize employees of color for their accomplishments and demonstrated excellence in their profession. Part III Part III, Section A, Line 3 The amount of Bad Debt attributed to financial assistance patients is based on actual writeoffs. The Bad Debt amount should be treated as a community benefit as it is similar to Unreimbursed Financial Assistance, as reported and allowed (Part I Line 7a), but for a different population. Part III, Line 4 There is no footnote in the Audited Financial Statements that describes Bad Debt. The amount of Bad Debt expense on Line 2 $4,183,567 is from our general ledger and is based on the treatment of Bad Debt activity consistent with Generally Accepted Accounting Principles (GAAP). Part III, Line 8 The Medicare allowable costs of $160,028,087 come directly from the Medicare cost report and are based on Medicare's cost finding principles and methodologies. We strongly believe that the entire amount of the shortfall $15,892,453 should be treated as a community benefit, as this represents the Institute's commitment to the elderly and disabled community by providing services that are not reimbursed. Part III, Line 9b Within DFCI's credit and collections policy there are provisions that describe collection practices to be followed for patients who are known to qualify for charity care or financial assistance in accordance with federal and Massachusetts law. Part V Part V, Section A DFCI main campus is at 450 Brookline Ave., Boston, MA. Its following satellite locations (below) each operate under the same hospital license. Dana-Farber/Brigham and Women's Cancer Center at Faulkner Hospital 1153 Centre Street, Boston, MA 02130 Dana-Farber/Brigham and Women's Cancer Center at Milford Hospital 20 Prospect Street, Milford, MA 01757 Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital 101 Columbian Street, South Weymouth, MA 02190 Dana-Farber at St. Elizabeth's Medical Center 736 Cambridge Street, Cushing Pavilion, 5th Floor, Brighton MA 02135 Part VI Part VI, Line 2 - Needs Assessment DFCI evaluates the appropriateness and effectiveness of prevention programs and has continued to focus on the incorporation of evidence-based approaches. The following resources are used to gather additional information. Community Benefits staff work to disseminate findings derived from DFCI's Center for Community Based Research (CCBR) projects to strengthen the design, implementation and evaluation of our cancer control programs. Dana-Farber staff continues to serve on various statewide and regional committees including the Massachusetts Comprehensive Cancer Control Coalition, and Boston Public Health Commission's Health Equity Committee. DFCI staff participates in local coalitions that seek to improve the health status of neighborhood residents. In partnership with these Coalitions, DFCI will continue to develop cancer prevention programs to meet the unique needs of these communities. DFCI has established a number of committees to assist in program evaluation including the Board of Trustees Community Programs Committee, the External Advisory Committee and the DFCI Internal Community Benefits Committee. An enhanced program evaluation protocol was developed this past year using the Redcap database that will generate program evaluation reports. Part VI, Line 3 - Patient Education of Eligibility for Assistance DFCI recognizes that some patients will not be able to pay for services rendered and may not be aware of the availability of available assistance. The Institute will also notify the patient about available DFCI financial assistance and payment plans that may be available to them. For those patients who are uninsured or underinsured, the Institute may assist patients in applying for coverage of services within a financial assistance program to cover some or all of their unpaid hospital bills, such as Mass Health, Care plus, Connector Care, Qualified Health Plan (QHP), Children's Medical Security Plan, Healthy Start, Health Safety Net, as well as a Medical Hardship discount based on the patient's documented income and allowable medical expenses. The Institute will provide, upon request, specific information about the eligibility process to be a Low Income Patient under the Massachusetts Health Safety Net Program. The Institute posts a signs regarding the availability of financial assistance in each registration office. Posted signs are clearly visible and legible to patients visiting these areas. The posted signs are poster size 12' by 18', font size , in English and Spanish. The Institute provides patients with information about financial assistance with each bill it sends to patients and in phone conversations with patients regarding bills. Part VI, Line 4 - Community Information DFCI serves a broad geographic and demographic community. DFCI's main campus is located in the Longwood Medical Area of the City of Boston. During FY14, DFCI worked closely with clinical partners to operate convenient, community-based centers in Milford, Massachusetts, Boston, Massachusetts (Faulkner), Brighton, Massachusetts (St. Elizabeth's), Weymouth, Massachusetts and Londonderry, New Hampshire. DFCI also helps to enhance the cancer care and services at local community hospitals and health centers such as Whittier Street Health Center in Boston, Massachusetts and Lawrence & Memorial Cancer Center in Waterford, Connecticut. Approximately seventy percent of DFCI's patients reside in Massachusetts. A substantial portion of other patients reside in New Hampshire, Maine, Connecticut, Rhode Island and New York. Women constitute approximately sixty-three percent of DFCI's patients (approximately 35,000 per year); with men constituting thirty seven percent (approximately 20,000 per year). DFCI's patients include children and adults; although approximately sixty five percent of patients range between forty and sixty-nine years of age. DFCI's focuses its community outreach efforts on its priority Boston neighborhoods of Roxbury, Mission Hill, Dorchester, Mattapan and Jamaica Plain (which collectively comprise 38% of Boston's overall population). According to the 2005-2009 American Community Survey, in Mattapan and Roxbury/Mission Hill, 87.8% and 53.1% of residents respectively identified themselves as Black. Approximately one-quarter of residents in Roxbury/Mission Hill (22.5%) and Jamaica Plain (20.9%) identified themselves as Latino. Census data show that in Roxbury/Mission Hill, 40.5% of individuals live in poverty, as do 39.4% of individuals in Mattapan. Part VI, Line 5 - Promotion of Community Health Community outreach at DFCI focuses on increasing awareness about the importance of cancer prevention, outreach, screening, early detection and clinical trials education. Examples of prevention programs are: 1. DFCI's Mammography Van (DFMV) DFCI's Mammography Van was launched as a joint venture between the City of Boston and DFCI in April 2002. The Van continues to be the only mobile mammography program in the Commonwealth of Massachusetts. It provides digital screening mammograms and breast health education to women 40 years of age and older. In partnership with 19 community-based organizations and neighborhood health centers, the Van is on the road 3-4 days per week year-round, serving all of Greater Boston. Ultimately, it aims to decrease breast cancer morbidity and mortality among medically underserved women and increase survival rates for those diagnosed with breast cancer. The mammogram on the van is treated as a point of entry into the larger health care system. Women who lack a primary care provider are referred to one of our partner Boston neighborhood health centers, and those who lack health insurance are encouraged to apply to the Connector. Priority populations include women who are low-income, elderly, immigrant, non-English speaking, and those of ethnic/racial and other minority backgrounds. Priority neighborhoods in Boston include Roxbury, Mattapan, Jamaica Plain, Dorchester and the South End. The Van provides an effective way for women to continually monitor their breast health and to stay connected to the health care system at large. Building on their shared commitment to caring for community residents, Dana-Farber opened a mammography suite within the Whittier Street Health Center, located in Boston's Roxbury and the program also hired a breast health educator/community outreach coordinator to strengthen our partnerships and the breast education provided to mammography patients. From May 2014 through the end of the fiscal year, there were over 400 breast health outreach contacts. In FY14, the Van provided 2,108 mammograms. Since program inception, Dana- Farber's Mammography Van has provided more than 39,000 mammograms to more than 17,000 unique patients. The largest racial and ethnic groups seen on the Van are Black (28%) and Latino (27%). Over the past year, almost 53% of van patients spoke a first language other than English. Van patients speak 38 different languages, including Spanish; Cape Verdean Creole; Haitian Creole; Portuguese; and Vietnamese. One hundred and eighteen breast cancer diagnoses have been confirmed for patients originally screened on the Van since program inception. Sixty-nine percent (68.7%) of patients screened on the Van were returnees from prior years; 40% of van patients returned for re-screening in a "timely" manner (12-18 months from last screen). Eleven percent (11.4%) of van patients served this year had their baseline (first-ever) mammograms on the van. Two-hundred and seventy patients (12.8%) screened on the van in the past year received a recommendation for follow-up. Over the past year, the insurance status of van patients was: less than 1% uninsured; 58.6% publicly insured (Medicare, MassHealth, Health Safety Net, etc); and 41.3% privately insured. 2. HPV and Cervical Cancer Pilot Education Program The most recent Community Health Needs Assessment found that cervical cancer mortality rates are higher among Black and Latino minorities in Boston. To address these findings, Community Benefits partnered with Team Maureen, a non-profit organization whose mission is to raise awareness about HPV and cervical cancer. The goal of the partnership is to combine efforts to educate parents and guardians on cervical cancer prevention to help them make informed decisions about their children's health. In FY 14, Dana-Farber served on the steering committee of the newly funded grant project with MDPH with the aim of increasing HPV vaccination coverage among adolescents and to achieve the Healthy People 2020 goal of 80% of adolescents in the state receive 3 doses of the HPV vaccine by 13-15 years of age, regardless of race/ethnicity or socioeconomic status. Additionally, Dana-Farber launched the HPV and Cervical Cancer Education Program pilot during a 5 week period in the summer of 2014 in partnership with Sociedad Latina, a community-based non-profit organization working with Latino true AMERICAN CANCER SOCIETYTOBACCO FREE MA 250 Williams ST NW Atlanta GA 30303 131788491 501(C)(3) 15000 CANCER RESEARCH AND DEVELOPMENT CURESEARCH 4600 East West Highway No 600 Bethesda MD 20814 954132414 501(C)(3) 7500 CANCER RESEARCH AND DEVELOPMENT FENWAY HIGH SCHOOL 174 Ipswich Street Boston MA 02215 046719813 501(C)(3) 20000 CANCER RESEARCH AND DEVELOPMENT Friend's of Dana-Farber 450 Brookline Ave BOSTON MA 02215 371613621 501(C)(3) 50000 CANCER RESEARCH AND DEVELOPMENT LEUKEMIA & LYMPHOMA SOCIETY 1311 Mamaroneck Ave Suite 310 White Plains NY 10605 135644916 501(C)(3) 40000 CANCER RESEARCH AND DEVELOPMENT LONGWOOD SYMPHONY ORCHESTRA 10 Guest Street No 295 Boston MA 02135 042921296 501(C)(3) 10000 CANCER RESEARCH AND DEVELOPMENT MADISON PARK DEVELOPMENT CORPORATION 184 Dudley St Roxbury MA 02119 237164223 501(C)(3) 10000 CANCER RESEARCH AND DEVELOPMENT PROSTATE HEALTH EDUCATION NETWORK INC 500 Victory Rd 4th Fl Quincy MA 02453 331042404 501(C)(3) 30000 CANCER RESEARCH AND DEVELOPMENT RESEARCH AMERICA 1101 King Street No 520 Alexandria VA 22314 521609875 501(C)(3) 7500 CANCER RESEARCH AND DEVELOPMENT SOCIEDAD LATINA INC 1530 Tremont St Roxbury MA 02120 042678255 501(C)(3) 10500 SOCIETY FOR INTERGRATIVE ONCOLOGY 136 Everett Road Albany NY 12205 331071221 501(C)(3) 6000 THE BREAST CANCER RESEARCH FOUNDATION 60 East 56th Street 8th FL New York NY 10022 133727250 501(C)(3) 15000 THE SCHWARTZ CENTER For Care 205 Portland St 6th FL Boston MA 02114 041564655 501(C)(3) 10000 UNITED WAY OF MASSACHUSETTS BAY 51 Sleeper St Boston MA 02210 042382233 501(C)(3) 25000 VISITING NURSE ASSOCIATION OF BOSTON 500 Rutherford Avenue Chalrestown MA 02129 042105800 501(C)(3) 6000 WHITTIER STREET HEALTH CENTER 1290 Tremont St Roxbury MA 02120 042619517 501(C)(3) 159270 16 Part IV All grants and donations were given to 501(c)(3) organizations to fulfill their missions. X false true X X X X X false true false false false false false true false Benz Edward J JR MD Trustee, President and CEO 756784 133550 269694 0 98632 0 216655 0 20162 0 1361927 133550 0 0 Nathan David G MD Trustee & Physician 223871 0 0 0 -82 0 20060 0 20169 0 264018 0 0 0 Boskey Richard S ESQ Asst Sec & General Counsel 449143 0 68048 0 19390 0 36390 0 28275 0 601246 0 0 0 Puhy Dorothy COO & EVP 607500 0 92040 0 45242 0 36390 0 9338 0 790510 0 0 0 Bird Karen CFO & Asst. Treasurer 384750 0 58292 0 9700 0 36390 0 28555 0 517687 0 0 0 Bartel Sylvia VP of Pharmacy Services 217501 0 17855 0 -6530 0 30203 0 25101 0 284130 0 0 0 Bunnell Craig A MD Chief Medical Officer 405000 0 47833 0 14587 0 36390 0 8591 0 512401 0 0 0 Gettleman Wendy VP of Facilities Management 216075 0 0 0 -6652 0 32131 0 25846 0 267400 0 0 0 Griffin James D MD Chair of Medical Oncology 538269 0 83892 0 36299 0 36390 0 22559 0 717409 0 0 0 Johnson Bruce Chief Clinical Research Office 453333 0 17207 0 27524 0 54715 0 17259 0 570038 0 0 0 Megdal Maria SVP of Institute Operations 311906 0 25163 0 5523 0 36390 0 12246 0 391228 0 0 0 Paresky Susan SVP of Development 499955 0 75746 0 28002 0 36390 0 24457 0 664550 0 0 0 Rollins Barrett J MD PHD Chief Scientific Officer 510591 0 78358 0 31179 0 36390 0 13891 0 670409 0 0 0 Shulman Lawrence N MD Chief of Staff 561217 0 90028 0 39278 0 36390 0 19214 0 746127 0 0 0 Constantine Michael MD Milford Med Dir-Hematol Onc 559996 0 171627 0 35371 0 23640 0 23627 0 814261 0 0 0 Kaddis Mona MD Medical Oncologist Milford 504003 0 121608 0 37402 0 23640 0 10106 0 696759 0 0 0 Kantoff Phillip MD Chief Clinical Research Office 488594 0 86150 0 27740 0 36390 0 27232 0 666106 0 0 0 Nadler Lee MD SVP for Experimental Med 535068 0 81066 0 34958 0 36390 0 23465 0 710947 0 0 0 Winer Eric MD Chief of Div of Women's Cancer 475875 0 21527 0 87509 0 41390 0 32063 0 658364 0 0 0 Herring Thomas Former Key Employee 149085 0 0 0 -10814 0 11460 0 20384 0 170115 0 0 0 Reid Ponte Patricia Former Key Employee 354375 0 56023 0 9268 0 36390 0 14934 0 470990 0 0 0 Sallan Stephen E MD Former Key Employee 418677 0 65275 0 19875 0 36390 0 21842 0 562059 0 0 0 Schedule J, Part 1, Line 4b The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Benz, Edward J. JR., MD 79,417 Boskey, Richard S., ESQ 24,268 Puhy, Dorothy 44,063 Bird, Karen 16,219 Bunnell, Craig A., MD 18,750 Griffin, James D., MD 35,409 megdal, Maria 7,113 Paresky, Susan 30,619 Reid Ponte, Particia, RN 12,422 Rollins, Barrett, MD, PHD 31,949 Sallan, Stephen E., MD 20,460 Shulman, Lawrence N., MD 38,277 Constantine, Michael, MD 38,124 Kaddis, Mona, MD 31,125 Nadler, Lee, MD 35,009 Winer, Eric, MD 27,609 Johnson, Bruce, MD 24,792 Kantoff, Phillip, MD 29,199 Part I Question 7 During the year, the CEO, COO, CFO, General Counsel, and the Key Employees were eligible to receive an incentive payment, a portion of which was a non-fixed payment payable at the discretion of the CEO and in the case of the CEO, the Compensation Committee, if the organization meets certain financial performance goals. The maximum possible non-fixed portion of these incentive payments ranged from 8% to 4% of base salary. A Mass Health and Educational Facilities 042456011 57586CZ24 2008-05-22 296490068 See Part VI false false false B Massachusetts Development Finance Agency 043431814 2012-07-02 57500000 See Part VI false false false A 57500000 0 301826729 8173929 4119476 0 2015100 116494 0 90335422 197066308 0 2011 true false true true B 0 0 57500000 0 0 0 0 0 0 0 57500000 0 2012 true false true true A false false true true true true 0 false false false true B false false true true true true 0 false false false true A false false false true true true Morgan Stanley 39.8 false false true Trinity Funding 2.8 true false true B false false false true true true Morgan Stanley 39.8 false false false 0 false true A true B true Part I (Bond Issues): A (a) Issuer name: Massachusetts Health and Educational Facilities Authority, succeeded by Massachusetts Development Finance Agency A (f) Description of purpose: The bond issue was used to refund Pool J-1 issued on June 30, 1993; Pool J-2 issued on June 8, 1995;Pool M-2 issued on May 30, 2002; Series H issued on May 4, 2004; Series I issued on February 8, 2007 and to partially finance the construction of the Yawkey Center for Cancer Care. B (f) Description of purpose: The bond issue was used to refund part of Series L-2 bonds issued on 5/22/2008. Part IV (Arbitrage): A2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2014 B2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2014 A4(b) Name of provider: Morgan Stanley Capital Services, Inc. B4(b) Name of provider: Morgan Stanley Capital Services, Inc. A5(b) Name of provider: Trinity Funding Company, LLC Patricia Ponte Tuition Assistance X 117395 19095 false true true Stephen Sallan Tuition Assistance X 262081 92184 false true true Bruce Johnson Housing Loan X 400000 88333 false true true Lee Nadler Tuition Assistance X 403154 49404 false true true Edward Benz Housing Loan X 600000 321666 false true true Eric Winer Tuition Assistance X 401067 291029 false true true Phillip Kantoff Tuition Assistance X 302458 239317 false true true Karen Bird Tuition Assistance X 49550 34999 false true true 1136027 New England Patriots See Part V See Part V false Boston Red Sox See Part V See Part V false Stop and Shop Supermarket Cos See Part V 109000 See part V false Berkshire Partners See Part V 961055 See part V false Bain Capital See Part V 571236 See Part V false Bristol Myers Squibb See Part V 19348628 See Part V false ONCOPEP See Part V See Part V false ACETYLON See Part V See Part V false Part IV New England Patriots Robert Kraft is the owner of the New England Patriots. The Patriots practice field is named for DFCI (at no cost to DFCI). Although the value of goods and services exchanged between DFCI and the New England Patriots is under the reporting threshold, DFCI reported the relationship in any event. Boston Red Sox Lawrence Lucchino is the President and CEO of the Boston Red Sox. The Boston Red Sox have a longstanding relationship with DFCI and the Jimmy Fund. Although the value of goods and services exchanged between DFCI and the Boston Red Sox is under the reporting threshold, DFCI reported the relationship in any event. Stop and Shop Supermarket Cos During the reporting period, Joseph Kelley was President and CEO of the New England Division of Stop and Shop Supermarket Cos. During FY 14, DFCI purchased $109,000 in gift cards for the Institutes patient assistant programs and as required, DFCI reported this transaction. Berkshire Partners Dana-Farber, Inc. (DFI), an organization related to DFCI, holds interests in alternative investments managed by Berkshire Partners. During FY 14, DFI transferred approximately $961,055 into these investments. Richard Lubin owns >5% of Berkshire Partners LLC. Bain Capital Dana-Farber, Inc. (DFI), an organization related to DFCI, holds interests, through an investment pool, in alternative investments managed by Bain Capital. During FY 14, DFI transferred approximately $571,236 into these investments. Joshua Bekenstein owns >5% of Bain Capital. Bristol Myers Squibb Fran Heller was a Senior Vice President at Bristol Myers Squibb (BMS) through June 2014. During FY 14, BMS transferred $496,500 to DFCI under sponsored research agreements $2,852,128 in connection with clinical trials and $16,000,000 for licensing. OncoPep Marc Cohen is on the board of and owns stock in OncoPep. Dana-Farber licensed technology to OncoPep and received shares in Oncopep in exchange for the license. Eventually DFCI could receive royalty payments from OncoPep. Sean Dobsons wife, Joselyn, is on the board of directors of OncoPep. Acetylon Marc Cohen is the Chairman of the Board of Acetylon Pharmaceuticals. Marc Cohen, Sean Dobson, Robert Kraft, and Rebecca Sanders own directly or indirectly interests in Acetylon Pharmaceuticals. DFCI licensed technology to Acetylon. DFCI owns stock in Acetylon. DFCI has not yet received any payments related to the license. X 997363 Letter from Donor X 22 198917 Letter from Donor X Airline & Hotel Stay 1 70035 Letter from Donor X Advertising 15 4194482 Letter from Donor X Event/Venue Production 3 67084 Letter from Donor X Miscellaneous 3 127130 Letter from Donor false true false Schedule M, Part I, Line 33 DFCI received donations of art, books, and other goods that it displays in its properties. These goods have values that are either nominal or are not readily determinable, and are therefore not included as revenue. Business & Family Relationships: Family Relationship: David Perini and Eileen Perini and Daughter Jennifer Perini Family Relationship: Richard Smith, Susan Smith, and Daughter Amy Berylson Family Relationship: Deborah First and Robert First Business Relationship: Richard Lubin and Christopher Hadley Business Relationship: Neal Curtin and Amy Kyle BUSINESS RELATIONSHIP: CHARLES DANA III AND ED ROVER PART VI, QUESTION 4 THE BYLAWS OF DFCI WERE AMENDED AND ADOPTED BY THE BOARD OF TRUSTEES ONCE SINCE THE LAST 990 WAS FILED,EFFECTIVE JANUARY 28, 2014. SIGNIFICANT AMENDMENTS TO THE BYLAWS WERE MADE FOR THE FOLLOWING REASONS: - TO DECREASE THE MAXIMUM NUMBER OF GOVERNING (VOTING) TRUSTEES FROM 85 TO 70; - TO ADD A DISTINGUISHED (NON-VOTING) TRUSTEE CATEGORY FOR TRUSTEES WHO REACH THE AGE OF 75 OR WHO HAVE SERVED ON THE BOARD FOR 20 YEARS; - TO PROVIDE THAT COMMITTEE CHAIRS SHALL BE ELECTED BY THE BOARD, RATHER THAN APPOINTED BY THE BOARD CHAIR; AND - TO CHANGE THE COMPOSITION OF THE EXECUTIVE COMMITTEE TO INCLUDE COMMITTEE CHAIRS, OFFICERS AND ADDITIONAL GOVERNING TRUSTEES. Part VI, Question 11 Process used to review the Form 990 The Form 990 is prepared by the Tax Department and independently reviewed by Ernst & Young, LLP for technical tax issues. After the Tax Department and Ernst & Young, LLP finalizes the returns, The Chief Financial Officer of the Organization meets with the Tax Department to review the tax return. If any changes need to be made, the Tax Department will make the changes in accordance with the CFO. After the CFO approves the return, certain sections are taken to Board Committees for a more detailed analysis. For example, the Board Compensation Committee reviews all information related to compensation in Part VII and Schedule J. Once the return has been through the committees who review certain sections, the tax return is presented to the Audit Committee for review and approval. After the audit committee approves the tax return, an electronic message is sent to all Board members with a secured link to the tax return. The Board has the opportunity to review the return and if any issues arise, they can bring them to the appropriate executive management individuals. A final version of the form is made available to the Board before filing with the IRS. The return is only filed after each of the steps in the review process is complete. Part VI, Question 12c Monitoring & Enforcement of Conflict of Interest Policy The Office of General Counsel, the Assistant Secretary of the Board, and the Tax Department drafts a Conflict of Interest Disclosure Questionnaire each year and has all trustees, officers, and key employees fill out a questionnaire in regards to their personal situation and personal and business relationships. The Assistant Secretary compiles the list of Disclosures and gathers financial data from the Accounts Payable and Payroll Department for all organizations, employees, independent contractors, and other miscellaneous transactions which were disclosed by all individuals. Once all of this information is compiled, the Office of General Counsel and the Tax Department goes through each transaction and disclosure to determine what needs to be disclosed on the tax return. The Tax Department and the Office of General Counsel also discusses if there are any other known transactions that have not been disclosed. If there are any questions regarding such situation, the Office of General Counsel and the Assistant Secretary will discuss the questions with the individual trustees, oficers and key employees involved. In addition the process described above, the governance committee of the board of directors annually reviews any new conflict of interest disclosures and they address any issues that may arise. The governance committee is also responsible to bring any major issues related to the conflict of interest policy to the executive committee and the entire Board if deemed necessary. Per DFCI's conflict of interest policy, in order to avoid a conflict of interest or an appearance of a conflict of interest: 1. A Trustee should not participate in a vote on a transaction in which the Trustee or family member has a financial interest and should disclose any potential conflict before DFCI acts on the transaction. 2. A Trustee, a member of his or her family, or an entity with which one or more of them has a material interest, may not do business with DFCI unless expressly authorized by DFCI after full disclosure. 3. A Trustee should fully disclose his or her association (including employment, consulting, or membership on a governing board by the Trustee or a family member) with an entity that competes with or has interests conflicting with those of DFCI and should refrain from participating in any vote if the vote affects DFCI. Once a disclosure has been made, DFCI's Office of General Counsel reviews such conflict and may discuss the matter with the appropriate parties. The Office of General Counsel will then review the matter with the Chairman of the Board. Final decisions are made with the chairman and possibly the Board's Executive Committee. Part VI, Question 15a Process for determining compensation of President Per DFCI's Executive Compensation Philosophy, annually the Compensation Committee of the Board of Trustees reviews the President's (DFCI's Chief Executive Officer) performance and makes a recommendation regarding compensation to the Executive Committee. The Executive Committee acts on the recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Executive Committee is reported to the full Board. Annually, following the filing of Form 990s, DFCI compares the information it reports for its President to the compensation of Presidents/CEO's at other area healthcare organizations as well as other institutions that are considered designated comprehensive cancer centers. The Board completed this process as of June 25, 2013. Part VI, Question 15b Process for determining compensation of officers and key employees Per DFCI's Executive Compensation Philosophy, annually the DFCI President reviews the performance of Officers and Key Employees and makes a recommendation as to their compensation to the Compensation Committee of the Board of Trustees. The Compensation Committee establishes compensation for those individuals based on that recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Compensation Committee is reported to the Executive Committee of the Board of Trustees and to the full Board. Annually, following the filing of Form 990s DFCI compares the compensation of these individuals with those at other area healthcare organizations as well as other institutions that are considered designated cancer centers. Part VI, Question 19 Availability of Governing Documents, Conflict of Interest Policy, and Financial Statements to the Public Governing Documents - Governing Documents - We currently provide the governing documents upon request. The Governing Documents are also available to the Public on the Secretary of the Commonwealth's website. Conflict of Interest Policy - DFCI's Conflict of Interest Policy can be found within its Code of Conduct, which is available on its website. Financial Statements - The organization uses the services of Digital Assurance Certification LLC (DAC) to report annual audited financial statements and other relevant organizational information as required by certain regulatory and tax laws. DAC is a website (www.dacbond.com) free to the public that publishes tax-exempt bond issuers' financial and legal documents such as the Audited Financial Statements. Fiscal Year 2001 through the latest issue date of the Audited Financial Statements for Dana-Farber Cancer Institute, Inc. can be found on the DAC website. PART XI LINE 9 OTHER CHANGES IN NET ASSETS CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATE $77,195,297 CHANGE IN VALUE OF SWAP AGREEMENT $(5,614,881) PENSION ADJUSTMENT $(2,774,000) OTHER CHANGES IN NET ASSETS 5,832,189 Total Other Changes in Net Assets 74,638,605 Part IX Line 11g Description of OTHER FEES FOR SERVICES OTHER FEES FOR SERVICES $87,564,235 PURCHASED RESEARCH SERVICES $ 40,205,937 ACCOUNTING FEES FOR SERVICES $ 489,333 -------------- TOTAL OTHER FEES $110,347,971 FORM 990 PART IX LINE 11G DESCRIPTION:ACCOUNTING FEES FOR SERVICES TOTAL FEES:489333 FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED RESEARCH SERVICES TOTAL FEES:40205937 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER FEES FOR SERVICES TOTAL FEES:87564235 Dana-Farber Inc 450 Brookline Avenue BP418 BOSTON MA 02215 043102433 INVEST MGMT MA 501(c)(3) 11A, TYPE 1 DFCI true DANA-FARBER TRUST INC 450 Brookline Avenue BP418 BOSTON MA 02215 300195757 DFCI RE MGMT MA 501(c)(3) 11A DFCI true DANA-FARBERPARTNERS CANCER CARE INC 450 Brookline Avenue BP418 BOSTON MA 02215 043320640 ONCOL SUP ORG MA 501(c)(3) 11c FI DFCI false RMSA TRUST 450 Brookline Avenue BP418 BOSTON MA 02215 562656539 RETRMT TRUST MA 501(c)(9) DFCI true Friends of Dana-Farber Cancer Institute 450 Brookline Ave BP418 Boston MA 02215 371613621 Fundraising MA 501(c)(3) 11A, TYPE 1 DFCI true Dana-FarberChildren's Hospital Cancer C 450 Brookline Ave BP418 Boston MA 02215 043554536 Pediatric Onc MA 501(c)(3) Type 1 N/A Dana-Farber Cancer Care Network Inc 450 Brookline Avenue BP 418 Boston MA 02215 465138314 ONCOL SUP ORG MA 501(c)(3) Type 1 DFCI true DANA-FARBERPARTNERS CANCER CARE 450 Brookline Avenue BP418 BOSTON MA 02215 043402364 ONCOLOGY PTNR MA Related 47503778 0 false 0 0.50000 false true true false false false false false false false false true false false true false false true true Dana-Farber Partners Cancer Care Inc O 133550 CASH Dana-Farber Partners Cancer Care Inc R 353990 CASH Dana-Farber Partners Cancer Care Inc L 29564715 CASH Dana-Farber Inc R 124287991 CASH Dana-Farber Inc S 173139401 CASH Friends of Dana-Farber Cancer Institute Inc O 221170 Actual Expense RMSA Trust R 149884 CASH Friends of Dana-Farber Cancer Institute Inc B 75650 Cash Friends of Dana-Farber Cancer Institute Inc C 564777 Cash Dana-Farber Cancer Care Network Inc L 6775357 COST Dana-Farber Cancer Care Network Inc R 9289993 COST Dana-Farber Cancer Care Network Inc R 1713791 Cost